The nurse administers a pain medication via IM injection to the patient. When should the nurse re-assess the patient's pain level?

Intramuscular analgesic administration involves deposition of medication into skeletal muscle tissue allowing systemic absorption through capillary perfusion, producing onset dependent on drug class, lipid solubility, and circulation with expected analgesic effect occurring within defined pharmacokinetic time window requiring reassessment. Rationale: A. 10 minutes after intramuscular injection is too early for most analgesics to reach therapeutic plasma concentration. IM absorption requires vascular uptake and systemic distribution. Pain relief is usually not fully established at this time, making assessment premature and unreliable for efficacy evaluation. B. 2 hours may be appropriate for some long-acting analgesics, but it exceeds the recommended initial reassessment window for most IM pain medications. Delayed evaluation risks prolonged untreated pain. Clinical guidelines emphasize earlier reassessment to ensure timely dose adjustment or additional intervention if needed. C. Within 1 hour is the standard reassessment time for most IM analgesics as peak effect typically occurs within this period depending on drug type. This allows evaluation of analgesic efficacy and detection of inadequate pain control for timely clinical intervention or dose adjustment. D. Once a shift is inappropriate for acute pain management following IM administration. Pain must be reassessed shortly after drug absorption begins, not at prolonged intervals. This approach risks uncontrolled pain, delayed response evaluation, and failure to meet effective pain management standards in clinical care.